First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA - Archive ouverte HAL Access content directly
Journal Articles Journal of Thoracic Oncology Year : 2021

First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA

(1) , (2) , (3) , (4) , (5) , (6) , (7) , (8) , (9) , (10) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (17) , (17) , (17) , (18)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

Dates and versions

inserm-03540850 , version 1 (24-01-2022)

Identifiers

Cite

D. Carbone, T. Ciuleanu, M. Cobo, M. Schenker, B. Zurawski, et al.. First-line Nivolumab + Ipilimumab + Chemo in Patients With Advanced NSCLC and Brain Metastases: Results From CheckMate 9LA. Journal of Thoracic Oncology, 2021, 16 (10), pp.S862. ⟨10.1016/j.jtho.2021.08.061⟩. ⟨inserm-03540850⟩
12 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More